| Financial Year |
September 30 2022 |
| Monetary Funds |
20,007,186.56 |
| Held-for-trading Financial Assets |
2,427,149.68 |
| Notes Receivable |
-- |
| Accounts Receivable |
-- |
| Advances to Suppliers |
1,610,388.71 |
| Other Receivables |
788,634,259.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
216,127,604.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
34,348.96 |
| Total Current Assets |
1,028,840,937.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
42,054,469.19 |
| Investment Properties |
-- |
| Fixed Assetes |
60,672.66 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
47,166,764.32 |
| Total Assets |
1,076,007,701.92 |
| Short-Term Loans |
298,458,980.15 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
23,820.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,758,942.04 |
| Taxes Payable |
93,410,504.30 |
| Interest Payable |
263,706,922.35 |
| Dividend Payable |
15,315.67 |
| Other payables |
297,240,086.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
119,722,908.54 |
| Other Current Liabilities |
200,000,000.00 |
| Sub-Total of Current Liabilities |
1,021,615,241.92 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,110,075.02 |
| Total Liabilities |
1,025,725,316.94 |
| Paid-In Capital(Or Share Stock) |
2,123,749,330.00 |
| Capital Surplus |
6,037,316,839.67 |
| Surplus Reserve |
193,147,185.28 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-8,303,930,969.97 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
50,282,384.98 |
| Owner's Equity（Stockholder's Equity） |
50,282,384.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,076,007,701.92 |
